Argentina players receive heroes’ welcome home despite World Cup defeat Al Jazeera · world 1h ago Read
Lebanese return to ‘pilot zone’ villages they say Israel never occupied Al Jazeera · world 2h ago Read
US military releases footage of tenth consecutive night of strikes on Iran Al Jazeera · world 2h ago Read
Who is driving diplomacy in the Horn of Africa and the Red Sea, and why? Al Jazeera · world 2h ago Read
A Ransomware Attack Just Halted Coca-Cola's Fairlife Production and Knocked the Stock Down 4%. Should Dividend Investors Care? NASDAQ · markets 3h ago Read
Guyana recovers 27 bodies after ferry disaster as crew comes under scrutiny Al Jazeera · world 3h ago Read
Why protests are growing in Ukraine over defence leadership and dismissals Al Jazeera · world 4h ago Read
Meta Stock's Rebound Made Mark Zuckerberg the World's Fifth-Richest Person at $222 Billion NASDAQ · markets 4h ago Read
What This Evolv Insider Sale Signals to Long-Term Investors as Revenue Jumped 45% NASDAQ · markets 4h ago Read
The New Jersey Financier Behind Trump Media’s Pivot Into Nuclear Energy Dow Jones · markets 4h ago Read
The Man Who Runs the IRS Spied on Colleagues When He Worked at JPMorgan Dow Jones · markets 4h ago Read
Tate brothers vow to fight extradition as they appear at court in Miami Al Jazeera · world 4h ago Read
Corcept's CFO Set His Selling Plan the Month the Stock Fell 50% — Here's What Investors Should Know NASDAQ · markets 5h ago Read
A Corcept Director Holds 1.5 Million Shares Through a 50% Crash and Rebound NASDAQ · markets 5h ago Read
Netflix Has Plummeted Over the Past Year and Just Dropped Again on Earnings. At 22 Times Profits, Is It a Buy? NASDAQ · markets 5h ago Read
Trump imposes 50% US tariffs on some Canadian goods, citing discrimination Al Jazeera · world 5h ago Read
Iran war live: Tehran attacks Gulf states, says 2 tankers in Hormuz on fire Al Jazeera · world 5h ago Read
Insurers Find Workarounds on Risky Debt as Regulators Play Whac-A-Mole Dow Jones · markets 5h ago Read
Nebius Stock Fell 40% From Its All-Time-High. Is This AI Stock Finally a Buy? NASDAQ · markets 5h ago Read
Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation TechCrunch · tech 6h ago Read
What This MannKind Director Sale Signals With $32.7 Million in Quarterly Royalties Revenue Potentially at Risk NASDAQ · markets 6h ago Read
Why This MannKind Insider Stock Sale Matters Less Than a 9% Royalty at Risk NASDAQ · markets 6h ago Read
What This Paychex Insider Sale Signals With Shares Down 20% in a Year — But Up 20% Since Earnings NASDAQ · markets 6h ago Read
The Armory Show reveals 230-gallery line-up and move to late September The Art Newspaper · culture 6h ago Read
What This Paychex Insider Filing Signals With Shares Down 20% This Past Year NASDAQ · markets 7h ago Read
Moderna Is Up 109% in 2026. Jim Cramer Just Called It 'Finally Investable Again.' Is the Stock a No-Brainer Buy on Its Recent Pullback? NASDAQ · markets 7h ago Read
